Radiologist and NIH director Dr Elias Zerhouni gave yet another talk on trends in the imaging sciences. He deserves special attention, since he is probably the only radiologist at the meeting who can actually direct those trends. I can talk about trends all day, but I have trouble controlling my seven- and nine-year-old sons.
Radiologist and NIH director Dr Elias Zerhouni gave yet another talk on trends in the imaging sciences. He deserves special attention, since he is probably the only radiologist at the meeting who can actually direct those trends. I can talk about trends all day, but I have trouble controlling my seven- and nine-year-old sons.
Zerhouni said a lot of fascinating things, and you should read his lecture when it shows up in Radiology. A couple of things stood out for me, especially the evolution of medicine from a curative model to a preemptive model. As Martha would say, "this is a good thing." One of the least favorite parts of my job is finding bad disease, well along its biologic course. I suspect that is one of my attractions to mammography, where most of the disease we find now is small and potentially treatable.
My take was that traditional anatomic imaging will be around for some time, in the diagnosis and treatment of acute disease. Dramatic changes will initially come in the realm of chronic disease. Imaging resolution will be measured in angstroms, not millimeters, and data will be far more quantitative. Function and biologic activity, along with detailed anatomy, will guide preemptive medicine, and if we are willing to step up to the plate, we can stay in the ballgame.
This is all very exciting, but I have to wonder who is going to do it. Physician polls in every specialty show doctors looking to retire ASAP. Most caution their kids away from medicine. Nonmedical frustrations and the economic pressures on providers are overwhelming, while the intangible benefits that used to come with being a "doctor" are nearly nonexistent.
This is not going to be work for dummies. Without those intangibles, are the best and brightest going into medicine or investment banking? One hopes the system will evolve back so we can concentrate on radiology and medicine, because that is the best job around.
On a lighter note, I spent much of the day seeking technologic solutions for a problem I see daily: biscuit poisoning. More specifically, imaging patients with BP. Clinicians can't examine these behemoths, so they send them to me. Ultrasound, plain films, and fluoro are often useless, so I want a CT designed for Mama Cass. I need a machine with high kV, higher mA, and a bore the size of the Lincoln Tunnel. I want to be able to turn off the dose modulators or whatever the vendor wants to call it. These folks suck up photons like Big Gulps, and I need clear images.
When I talk to the vendors, they all want to talk about radiation dose. Cow pies. If these patients were risk-averse, this wouldn't be an issue. You don't weigh over 350 pounds if you are truly worried about your health. Every one of them rode to the hospital in a car, and any ride in a car is far riskier than a CT done for appropriate clinical indications. I haven't found the perfect McScanner yet, but I'm looking.
Enough writing. It's time to go to the annual Philips party at the Art Institute. If this was the only thing I did in Chicago all week, the trip would be worth it. Mine is not a department committed to one brand, and I have always liked Philips machines. But I make sure they are always included in every search, because I like this party.
AI Facilitates Nearly 83 Percent Improvement in Turnaround Time for Fracture X-Rays
December 19th 2023In addition to offering a 98.5 percent sensitivity rate in diagnosing fractures on X-ray, an emerging artificial intelligence (AI) software reportedly helped reduce mean turnaround time on X-ray fracture diagnosis from 48 hours to 8.3 hours, according to new research presented at the Radiological Society of North America (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Can an Emerging PET Radiotracer Enhance Detection of Prostate Cancer Recurrence?
December 14th 2023The use of 68Ga-RM2 PET/MRI demonstrated a 35 percent higher sensitivity rate than MRI alone for the diagnosis of biochemical recurrence of prostate cancer, according to research recently presented at the Radiological Society of North America (RSNA) conference.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
Can AI Improve Detection of Extraprostatic Extension on MRI?
December 4th 2023Utilizing a deep learning-based AI algorithm to differentiate between diagnostic and non-diagnostic quality of prostate MRI facilitated a 10 percent higher specificity rate for diagnosing extraprostatic extension on multiparametric MRI, according to research presented at the recent RSNA conference.
Study: Regular Mammography Screening Reduces Breast Cancer Mortality Risk by More than 70 Percent
November 30th 2023Consistent adherence to the five most recent mammography screenings prior to a breast cancer diagnosis reduced breast cancer death risk by 72 percent in comparison to women who did not have the mammography screening, according to new research findings presented at the annual Radiological Society of North America (RSNA) conference.